Authors:	Singh, Shreya Patil, Anant Kianfar, Nika Waśkiel-Burnat, Anna Rudnicka, Lidia Sinclair, Rodney Goldust, Mohamad
Title:	Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?
Online publication date:	16-Jan-2023
Year of first publication:	2022
Language:	english
Abstract:	Minoxidil solution is used for the treatment of androgenetic alopecia (AGA). Minoxi dil 5% solution has been shown to have superior efficacy to minoxidil 2% solution, it is unknown whether concentrations of minoxidil > 5% provide additional clinical benefit. We performed a review of the literature to examine the evidence on the effi cacy and safety of higher concentrations of minoxidil in AGA. A search of the PubMed database was performed using the keywords ‘minoxidil’, ‘androgenic alope cia’ and ‘pattern hair loss’. Relevant articles, including clinical trials, other clinical studies, case series and case reports published in English were considered for review. In addition, relevant references from the bibliography section of the retrieved articles were also reviewed.
DDC:	610 Medizin 610 Medical sciences
Institution:	Johannes Gutenberg-Universität Mainz
Department:	FB 04 Medizin
Place:	Mainz
ROR:	https://ror.org/023b0x485
DOI:	http://doi.org/10.25358/openscience-8574
Version:	Published version
Publication type:	Zeitschriftenaufsatz
License:	CC BY
Information on rights of use:	https://creativecommons.org/licenses/by/4.0/
Journal:	Clinical and experimental dermatology 47 11
Pages or article number:	1951 1955
Publisher:	Wiley-Blackwell
Publisher place:	Oxford u.a.
Issue date:	2022
ISSN:	1365-2230
Publisher DOI:	10.1111/ced.15338
Appears in collections:	DFG-491381577-H